VULC3 Stock Overview
Vulcabras Azaleia S.A. operates as a footwear company in Brazil.
Vulcabras Azaleia Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||R$11.36|
|52 Week High||R$11.72|
|52 Week Low||R$7.87|
|1 Month Change||13.04%|
|3 Month Change||26.50%|
|1 Year Change||34.28%|
|3 Year Change||89.65%|
|5 Year Change||134.23%|
|Change since IPO||13.60%|
Recent News & Updates
Should You Think About Buying Vulcabras Azaleia S.A. (BVMF:VULC3) Now?
While Vulcabras Azaleia S.A. ( BVMF:VULC3 ) might not be the most widely known stock at the moment, it led the BOVESPA...
Why Vulcabras Azaleia S.A. (BVMF:VULC3) Could Be Worth Watching
Vulcabras Azaleia S.A. ( BVMF:VULC3 ), might not be a large cap stock, but it saw significant share price movement...
|VULC3||BR Luxury||BR Market|
|VULC3 Average Weekly Movement||6.0%|
|Luxury Industry Average Movement||6.3%|
|Market Average Movement||6.4%|
|10% most volatile stocks in BR Market||10.0%|
|10% least volatile stocks in BR Market||3.0%|
About the Company
Vulcabras Azaleia S.A. operates as a footwear company in Brazil. The company provides sports footwear, women’s shoes, and sports apparel products, as well as sandals and safety boots. It markets its products under the Azaleia, Dijean, Opanka, Olympikus, Olk, and Vulcabras brand names.
Vulcabras Azaleia Fundamentals Summary
|VULC3 fundamental statistics|
Is VULC3 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|VULC3 income statement (TTM)|
|Cost of Revenue||R$1.31b|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
Aug 02, 2022
|Earnings per share (EPS)||1.44|
|Net Profit Margin||17.37%|
How did VULC3 perform over the long term?See historical performance and comparison
Is Vulcabras Azaleia undervalued compared to its fair value and its price relative to the market?
Valuation Score 0/6
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Price To Earnings Ratio
Price to Earnings Growth Ratio
Price to Book Ratio
How is Vulcabras Azaleia forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings per Share Growth Forecasts
Future Return on Equity
How has Vulcabras Azaleia performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Return on Equity
How is Vulcabras Azaleia's financial position?
Financial Health Score0/6
Financial Health Score 0/6
Financial Position Analysis
Debt to Equity History and Analysis
What is Vulcabras Azaleia current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Forecast Dividend Yield
Dividend Yield vs Market
Stability and Growth of Payments
Earnings Payout to Shareholders
Cash Payout to Shareholders
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Mr. Pedro Bartelle serves as the Chief Executive Officer and Second Vice Chairman of Administrative Council at Vulcabras|azaleia S.A served as its , Chief Investor Relations Officer until 2019. Mr. Bartell...
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Vulcabras Azaleia S.A.'s employee growth, exchange listings and data sources
- Name: Vulcabras Azaleia S.A.
- Ticker: VULC3
- Exchange: BOVESPA
- Founded: 1952
- Industry: Footwear
- Sector: Consumer Durables
- Implied Market Cap: R$2.792b
- Shares outstanding: 245.76m
- Website: https://vulcabrasazaleiari.com.br
- Vulcabras Azaleia S.A.
- Av. Antônio Frederico Ozanan, 1440
- São Paulo
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/21 00:00|
|End of Day Share Price||2022/05/20 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.